Jpmorgan Chase & CO 908 Devices Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in 908 Devices Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,939 shares of MASS stock, worth $29,972. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,939
Previous 10,633
2.88%
Holding current value
$29,972
Previous $54,000
31.48%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MASS
# of Institutions
87Shares Held
18.4MCall Options Held
14.1KPut Options Held
22K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.22MShares$8.82 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$5.14 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.84MShares$5.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$4.64 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY1.57MShares$4.31 Million0.75% of portfolio
About 908 Devices Inc.
- Ticker MASS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,590,200
- Market Cap $86.6M
- Description
- 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...